Related Experiment Video
Updated: May 20, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Dramatic Extrahepatic Cholestasis Improvement after Steroid Therapy.
Bagus Setyoboedi1,2, Rendi Aji Prihaningtyas1,2, Sjamsul Arief1,2
1Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Steroid treatment shows promise in infants with extrahepatic cholestasis potentially leading to biliary atresia. This approach may reduce inflammation and prevent disease progression, offering a new therapeutic avenue.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Care
Background:
- Biliary atresia is a significant cause of pediatric liver transplantation.
- Current treatments like Kasai surgery have limitations.
Observation:
- A case report details an infant presenting with jaundice, pale stools, and dark urine.
- Laboratory tests revealed elevated liver enzymes and cholestasis.
- Cytomegalovirus (CMV) infection was noted concurrently.
Findings:
- Percutaneous liver biopsy confirmed extrahepatic cholestasis.
- Treatment with steroids and ursodeoxycholic acid led to significant clinical and biochemical improvement.
- Improvements included reduced bilirubin levels, normalized liver enzymes, and increased hemoglobin.
Implications:
- Steroid administration may mitigate biliary system inflammation in extrahepatic cholestasis.
- This treatment could potentially halt the progression to biliary atresia.
- Further research into steroid therapy for biliary atresia is warranted.
More Related Videos
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...